Trial intelligence / Profile preview

Phase IV randomized open-label optimization of peginterferon alfa subtype switch plus ribavirin in relapsed chronic hepatitis C

ChiCTR-TRC-10001107Phase 4Completed

Sponsor

The Third Hospital of Hebei Medical University

Start

Jan 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1